Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Echo Therapeutics, Inc. stock logo
ECTE
Echo Therapeutics
$0.00
$0.00
$0.00
$0.28
N/AN/AN/AN/A
MAGAA
Magna-Lab
$0.85
+18.1%
$0.72
$0.11
$2.00
$1.00M7.513,117 shs38,522 shs
SCIE
SpectraScience
$0.00
$0.00
$0.00
$497K0.32N/A2.00 million shs
Trimedyne, Inc. stock logo
TMED
Trimedyne
$4.25
-0.2%
$4.25
$3.48
$7.00
N/AN/AN/A100 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Echo Therapeutics, Inc. stock logo
ECTE
Echo Therapeutics
0.00%0.00%0.00%0.00%0.00%
MAGAA
Magna-Lab
+47.03%+60.00%-24.80%+140.00%+728.54%
SCIE
SpectraScience
0.00%0.00%0.00%0.00%0.00%
Trimedyne, Inc. stock logo
TMED
Trimedyne
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Echo Therapeutics, Inc. stock logo
ECTE
Echo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
MAGAA
Magna-Lab
N/AN/AN/AN/AN/AN/AN/AN/A
SCIE
SpectraScience
N/AN/AN/AN/AN/AN/AN/AN/A
Trimedyne, Inc. stock logo
TMED
Trimedyne
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Echo Therapeutics, Inc. stock logo
ECTE
Echo Therapeutics
N/AN/AN/AN/A
MAGAA
Magna-Lab
N/AN/AN/AN/A
SCIE
SpectraScience
N/AN/AN/AN/A
Trimedyne, Inc. stock logo
TMED
Trimedyne
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Echo Therapeutics, Inc. stock logo
ECTE
Echo Therapeutics
N/AN/AN/AN/AN/AN/A
MAGAA
Magna-Lab
N/AN/AN/AN/A($1.52) per shareN/A
SCIE
SpectraScience
N/AN/AN/AN/AN/AN/A
Trimedyne, Inc. stock logo
TMED
Trimedyne
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Echo Therapeutics, Inc. stock logo
ECTE
Echo Therapeutics
N/AN/A0.00N/AN/AN/AN/AN/A
MAGAA
Magna-Lab
-$130K$0.184.72N/AN/A-12.32%42,399.99%N/A
SCIE
SpectraScience
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Trimedyne, Inc. stock logo
TMED
Trimedyne
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Echo Therapeutics, Inc. stock logo
ECTE
Echo Therapeutics
N/AN/AN/AN/AN/A
MAGAA
Magna-Lab
N/AN/AN/AN/AN/A
SCIE
SpectraScience
N/AN/AN/AN/AN/A
Trimedyne, Inc. stock logo
TMED
Trimedyne
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Echo Therapeutics, Inc. stock logo
ECTE
Echo Therapeutics
N/A
MAGAA
Magna-Lab
N/A
SCIE
SpectraScience
N/A
Trimedyne, Inc. stock logo
TMED
Trimedyne
N/A

Insider Ownership

CompanyInsider Ownership
Echo Therapeutics, Inc. stock logo
ECTE
Echo Therapeutics
7.00%
MAGAA
Magna-Lab
15.30%
SCIE
SpectraScience
0.50%
Trimedyne, Inc. stock logo
TMED
Trimedyne
11.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Echo Therapeutics, Inc. stock logo
ECTE
Echo Therapeutics
17N/AN/ANot Optionable
MAGAA
Magna-Lab
N/A1.18 millionN/ANot Optionable
SCIE
SpectraScience
54.97 billion4.94 billionNot Optionable
Trimedyne, Inc. stock logo
TMED
Trimedyne
N/AN/AN/ANot Optionable

SCIE, TMED, ECTE, and MAGAA Headlines

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Echo Therapeutics logo

Echo Therapeutics

OTCMKTS:ECTE
Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.

Magna-Lab

OTCMKTS:MAGAA
Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. The company was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.

SpectraScience

OTCMKTS:SCIE
SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.
Trimedyne logo

Trimedyne

OTCMKTS:TMED
Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.